IBEX 35
10.714,00 -51,00 (-0,47%) Euro Stoxx 50
4.926,64 -9,93 (-0,20%) Dólar/Euro
1,0673 +0,0027 (+0,26%) Petróleo Brent
86,46 -0,65 (-0,75%) Oro
2.396,80 -1,20 (-0,05%) Bitcoin EUR
61.287,07 +2.921,56 (+5,01%)
Haleon plc (HLN.L)
Haleon plc
The Heights
Building 5, First Floor
Weybridge KT13 0NY
United Kingdom
44 1932 822000
https://www.haleon.com
Sector(es): Healthcare
Sector: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 25.408
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Brian James McNamara | CEO & Executive Director | 3,39M | N/A | 1966 |
| Mr. Tobias Hannes Hestler | CFO & Executive Director | 1,88M | N/A | 1972 |
| Ms. Sonya Ghobrial | Head of Investor Relations | N/A | N/A | 1974 |
Descripción
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
Gobierno corporativo
El ISS Governance QualityScore de Haleon plc, a día 1 de abril de 2024, es 3. Las puntuaciones base son Auditoría: 6; Tablero: 4; Derechos de los accionistas: 6; Compensación: 4.
